Author Topic: (JAMA editorial) Cortical volume loss and neurologic dysfunction in MS  (Read 142 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9841
  • MS diagnosed 1980
  • Location: Pacific Northwest
Researchers in the MS field are paying closer attention to brain atrophy now, as is pointed out in this segment of an editorial in JAMA Neurology, June 13, 2016  (the first page of the editorial is reproduced below):

MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

Offline agate

  • Administrator
  • *****
  • Posts: 9841
  • MS diagnosed 1980
  • Location: Pacific Northwest
The same issue of JAMA Neurology contains an article, "Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis."

The abstract can be seen here.
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
77 Views
Last post December 24, 2017, 02:04:09 pm
by agate
0 Replies
95 Views
Last post May 28, 2018, 03:40:46 pm
by agate
0 Replies
84 Views
Last post June 29, 2018, 02:39:18 pm
by agate
0 Replies
172 Views
Last post August 26, 2019, 04:45:30 pm
by agate
0 Replies
12 Views
Last post December 25, 2023, 09:48:04 pm
by agate